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Abstract
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Parasympathetic innervation of meninges and ability of carbachol, acetylcholine (ACh) receptor
(AChR)  agonist,  to  induce  headaches  suggests  contribution  of  cholinergic  mechanisms  to
primary headaches. However, neurochemical mechanisms of cholinergic regulation of peripheral
nociception  in  meninges,  origin  place  for  headache,  are  almost  unknown.  Methods:  Using
electrophysiology,  calcium imaging, immunohistochemistry,  and staining of  meningeal  mast
cells, we studied effects of cholinergic agents on peripheral nociception in rat hemiskulls and
isolated trigeminal neurons. Results: Both ACh and carbachol significantly increased nociceptive
firing in peripheral terminals of meningeal trigeminal nerves recorded by local suction electrode.
Strong nociceptive firing was also induced by nicotine, implying essential role of nicotinic AChRs
in control of excitability of trigeminal nerve endings. Nociceptive firing induced by carbachol
was reduced by muscarinic antagonist atropine, whereas the action of nicotine was prevented
by the nicotinic blocker d-tubocurarine but was insensitive to the TRPA1 antagonist HC-300033.
Carbachol but not nicotine induced massive degranulation of meningeal mast cells known to
release  multiple  pro-nociceptive  mediators.  Enzymes  terminating  ACh  action,
acetylcholinesterase (AChE) and butyrylcholinesterase, were revealed in perivascular meningeal
nerves.  The  inhibitor  of  AChE  neostigmine  did  not  change  the  firing  per  se  but  induced
nociceptive  activity,  sensitive  to  d-tubocurarine,  after  pretreatment  of  meninges  with  the
migraine mediator CGRP. This observation suggested the pro-nociceptive action of endogenous
ACh  in  meninges.  Both  nicotine  and  carbachol  induced  intracellular  Ca  2+  transients  in
trigeminal neurons partially overlapping with expression of capsaicin-sensitive TRPV1 receptors.
Conclusion: Trigeminal nerve terminals in meninges, as well as dural mast cells and trigeminal
ganglion neurons express a repertoire of pro-nociceptive nicotinic and muscarinic AChRs, which
could  be  activated  by  the  ACh  released  from  parasympathetic  nerves.  These  receptors
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